White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Zilucoplan Auto-Injector for Adults with Generalized Myasthenia Gravis

Not recruiting

3 1 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:
- Zilucoplan Sodium
Study on Batoclimab for Patients with Thyroid Eye Disease

Not recruiting

3 1 1
Investigated diseases:
- Endocrine ophthalmopathy
Investigated drugs:
- Batoclimab
+1
Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

Not recruiting

3 1
Investigated diseases:
- Glioma
Investigated drugs:
- Vorasidenib
Study on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy

Not recruiting

3 1 1 1
Investigated diseases:
- Laryngeal squamous cell carcinoma
- Squamous cell carcinoma of the hypopharynx
Investigated drugs:
Study on Early Temozolomide Treatment for Adults with Glioblastoma

Not recruiting

3 1 1 1
Investigated diseases:
- Glioblastoma multiforme
- Glioblastoma
Investigated drugs:
- Temozolomide
Study Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Somapacitan
- Somatropin
+10
Study of Tepotinib for Patients with Advanced Lung Cancer with MET Exon 14 Skipping Alterations or MET Amplification

Not recruiting

2 1 1
Investigated drugs:
- Tepotinib
+1
Study on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer

Not recruiting

3 1 1
Investigated diseases:
- Gastrointestinal carcinoma
Investigated drugs:
Study on the Effects of Defosbarasertib and Durvalumab for Patients with Extensive-Stage Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Small cell lung cancer extensive stage
Investigated drugs:
- Durvalumab
Study of BAT3306 or pembrolizumab with chemotherapy (carboplatin and pemetrexed) in patients with stage IV non-squamous non-small cell lung cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer stage IV
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies